
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 1,097.90 |
| High | 1,140.00 |
| Low | 1,093.10 |
| Prev Close | 1,106.20 |
| Volume | 17,013 |
| VWAP(₹) | 1,104.59 |
| PE Ratio(x) | 14.47 |
| EPS - TTM(₹) | 76.95 |
| MCap(₹ Cr.) | 4,802.06 |
| MCap Rank | 27 |
| PB Ratio(x) | 2.15 |
| Div Yield(%) | 0.45 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 2,114.00 |
| 52W Low(₹) | 807.00 |
| MCap/Sales | 1.38 |
| Beta(1 Month) | - |
| BV/Share(₹) | 514.92 |
Employee & Interest Expense
Company has spent 2.85% of its operating revenues towards interest expenses and 5.13% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Meghmani Finechem Share Price Update
Epigral Ltd. share price moved up by 0.63% from its previous close of Rs 1,106.20. Epigral Ltd. stock last traded price is 1,113.10
| Share Price | Value |
|---|---|
| Today/Current/Last | 1,113.10 |
| Previous Day | 1,106.20 |
Found Insights useful?
| 1 Day | 0.63% |
| 1 Month | -4.12% |
| 3 Months | 32.67% |
| 1 Year | -38.17% |
| 3 Years | -0.13% |
| 5 Years | N.A. |
1 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | - | - | - | - |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 1 | 1 | 1 | 1 |
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 735.59 | 602.68 | 589.10 | 614.79 | 631.03 |
| Total Income Growth (%) | 22.05 | 2.31 | -4.18 | -2.57 | -2.78 |
| Total Expenses | 609.27 | 537.13 | 497.31 | 484.69 | 488.20 |
| Total Expenses Growth (%) | 13.43 | 8.01 | 2.60 | -0.72 | -1.50 |
| EBIT | 126.32 | 65.55 | 91.79 | 130.10 | 142.83 |
| EBIT Growth (%) | 92.71 | -28.59 | -29.45 | -8.91 | -6.93 |
| Profit after Tax (PAT) | 80.95 | 39.11 | 51.22 | 160.69 | 86.89 |
| PAT Growth (%) | 106.98 | -23.64 | -68.12 | 84.93 | -16.15 |
| EBIT Margin (%) | 17.17 | 10.88 | 15.58 | 21.16 | 22.63 |
| Net Profit Margin (%) | 11.00 | 6.49 | 8.69 | 26.14 | 13.77 |
| Basic EPS (₹) | 18.76 | 9.07 | 11.87 | 37.25 | 20.14 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent 2.85% of its operating revenues towards interest expenses and 5.13% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 3,505.30 | 3,152.44 | 2,794.34 | 2,432.24 | 2,123.67 |
| Total Assets Growth (%) | 11.19 | 12.82 | 14.89 | 14.53 | 46.59 |
| Total Liabilities | 1,283.87 | 1,247.91 | 1,485.24 | 1,253.14 | 1,397.70 |
| Total Liabilities Growth (%) | 2.88 | -15.98 | 18.52 | -10.34 | 82.81 |
| Total Equity | 2,221.43 | 1,904.53 | 1,254.10 | 1,069.10 | 725.97 |
| Total Equity Growth (%) | 16.64 | 51.86 | 17.30 | 47.27 | 53.41 |
| Current Ratio (x) | 1.16 | 1.57 | 0.64 | 0.65 | 0.84 |
| Total Debt to Equity (x) | 0.25 | 0.31 | 0.72 | 0.72 | 1.36 |
| Contingent Liabilities | 315.34 | 279.21 | 110.44 | 293.41 | 192.72 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 435.53 | 440.56 | 397.64 | 626.16 | 283.82 |
| Net Cash used in Investing Activities | -354.67 | -261.56 | -401.10 | -437.22 | -454.63 |
| Net Cash flow from Financing Activities | -94.48 | -163.54 | -7.60 | -199.79 | 195.22 |
| Net Cash Flow | -13.62 | 15.46 | -11.06 | -10.85 | 24.41 |
| Closing Cash & Cash Equivalent | 5.02 | 18.64 | 3.18 | 14.24 | 25.09 |
| Closing Cash & Cash Equivalent Growth (%) | -73.07 | 485.61 | -77.65 | -43.23 | 3,589.03 |
| Total Debt/ CFO (x) | 1.29 | 1.33 | 2.28 | 1.22 | 3.49 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 354.67 cr for investing activities which is an YoY increase of 35.6%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 14.94 | 18.78 | 15.61 | 33.04 | 34.82 |
| Return on Capital Employed (%) | 14.80 | 22.30 | 18.07 | 32.94 | 26.87 |
| Return on Assets (%) | 9.47 | 11.34 | 7.00 | 14.52 | 11.90 |
| Interest Coverage Ratio (x) | 8.09 | 13.63 | 6.64 | 10.64 | 11.60 |
| Asset Turnover Ratio (x) | 0.76 | 0.86 | 0.74 | 0.96 | 0.87 |
| Price to Earnings (x) | 10.53 | 22.94 | 23.26 | 11.10 | 16.03 |
| Price to Book (x) | 1.57 | 4.30 | 3.63 | 3.67 | 5.57 |
| EV/EBITDA (x) | 6.96 | 12.06 | 11.30 | 6.86 | 9.76 |
| EBITDA Margin (%) | 23.03 | 28.46 | 25.28 | 31.84 | 33.11 |
Found Financials useful?
No Data Available
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
MF Ownership as on 31 May 2026
135.37
Amount Invested (in Cr.)
0.5%
% of AUM
5.76
% Change (MoM basis)
57.45
Amount Invested (in Cr.)
0.39%
% of AUM
0.00
% Change (MoM basis)
29.10
Amount Invested (in Cr.)
1.73%
% of AUM
0.00
% Change (MoM basis)
General Meeting
-
May 14, 2026
Final
50%
May 04, 2026
Board Meeting
Audited Results & Final Dividend
Apr 27, 2026
| Announced on | Meeting on |
| Apr 27, 2026 | May 02, 2026 |
| Audited Results & Final Dividend | |
| Jan 20, 2026 | Jan 30, 2026 |
| Quarterly Results | |
| Nov 04, 2025 | Nov 10, 2025 |
| Quarterly Results | |
| Jul 29, 2025 | Aug 02, 2025 |
| Quarterly Results & Fund Raising | |
| Apr 23, 2025 | May 05, 2025 |
| Audited Results & Final Dividend | |
| Announced on | Ex-Date | Dividend% |
| May 04, 2026 | Jun 01, 2026 | 50% |
| May 05, 2025 | Jun 20, 2025 | 35% |
| Jan 27, 2025 | Feb 07, 2025 | 25% |
| Apr 22, 2024 | Jul 02, 2024 | 50% |
| Apr 25, 2023 | Jun 20, 2023 | 25% |
No Data Available
No Data Available
No Data Available
| Announced on | Meeting on |
| May 14, 2026 | Jun 08, 2026 |
| - | |
| Apr 17, 2026 | May 21, 2026 |
| - | |
| Jun 05, 2025 | Jun 28, 2025 |
| - | |
| Apr 15, 2025 | May 19, 2025 |
| - | |
| Aug 19, 2024 | Sep 18, 2024 |
| - | |
Epigral Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 4,802.06 Crore) operating in Chemicals sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Commodities, BSE AllCap, BSE NEXT 500, BSE MidSmallCap
Address
�Epigral Tower�,Behind Safal Profitaire,Corporate Road,Ahmedabad, Gujarat - 380015
Maulik Patel
Chairman & Managing DirectorKaushal Soparkar
Executive DirectorAnkit Patel
Non Exe.Non Ind.DirectorDarshan Patel
Non Exe.Non Ind.DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.